These findings contrast with those from studies showing that C3 and TCC were expressed on the apical membrane of IECs in patients with IBD and that CD59 was specifically reduced on IECs but not other cell types in patients with UC and CD, potentially causing complement-mediated destruction of the intestinal epithelium (33–35). This evidence concerns the gene C3 and inflammatory bowel disease.